
Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Revenue | $15.3B | $16.7B | $15.5B | $16.6B | $19.2B | |
Revenue Growth (YoY) | -0.76% | 9.21% | -7.22% | 6.69% | 16.14% | |
Cost of Revenues | $13.7B | $15.1B | $13.9B | $14.8B | $17B | |
Gross Profit | $1.6B | $1.6B | $1.6B | $1.8B | $2.2B | |
Gross Profit Margin | 10.63% | 9.66% | 10.6% | 10.79% | 11.35% | |
R&D Expenses | -- | -- | -- | -- | -- | |
Selling, General & Admin | -- | -- | -- | -- | -- | |
Other Inc / (Exp) | -- | -- | -- | -- | -- | |
Operating Expenses | $708.1M | $622.4M | $696M | $700.4M | $763.1M | |
Operating Income | $920.5M | $992.7M | $948.1M | $1.1B | $1.4B | |
Net Interest Expenses | $257M | $202.3M | -- | $273.9M | -- | |
EBT. Incl. Unusual Items | $288.9M | $890.9M | $1B | $892.1M | $1.6B | |
Earnings of Discontinued Ops. | $2.3M | -- | -- | -- | $2.2M | |
Income Tax Expense | $13.7M | $196.4M | $53.8M | $139.7M | $312.8M | |
Net Income to Company | $277.5M | $694.5M | $982.9M | $752.4M | $1.3B | |
Minority Interest in Earnings | -$2.3M | -$1.2M | -$5.3M | -$40.1M | -$92M | |
Net Income to Common Excl Extra Items | $275.2M | $693.3M | $977.6M | $712.4M | $1.2B | |
Basic EPS (Cont. Ops) | $0.24 | $0.60 | $0.85 | $0.62 | $1.01 | |
Diluted EPS (Cont. Ops) | $0.24 | $0.60 | $0.85 | $0.62 | $1.01 | |
Weighted Average Basic Share | $1.2B | $1.2B | $1.2B | $1.2B | $1.2B | |
Weighted Average Diluted Share | $1.2B | $1.2B | $1.2B | $1.2B | $1.2B | |
EBITDA | $1.4B | $1.6B | $1.7B | $1.7B | $2.4B | |
EBIT | $483.1M | $1.1B | $1.2B | $1.1B | $1.7B | |
Revenue (Reported) | $15.3B | $16.7B | $15.5B | $16.6B | $19.2B | |
Operating Income (Reported) | $920.5M | $992.7M | $948.1M | $1.1B | $1.4B | |
Operating Income (Adjusted) | $483.1M | $1.1B | $1.2B | $1.1B | $1.7B |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | $3.4B | $3.4B | $3.3B | $4B | $4.4B | |
Revenue Growth (YoY) | 17.58% | 0.33% | -3.39% | 22.13% | 9.96% | |
Cost of Revenues | $3.1B | $3.1B | $3B | $3.6B | $4B | |
Gross Profit | $244.6M | $246.9M | $277.1M | $374.7M | $386.2M | |
Gross Profit Margin | 7.28% | 7.32% | 8.5% | 9.42% | 8.82% | |
R&D Expenses | -- | -- | -- | -- | -- | |
Selling, General & Admin | -- | -- | -- | -- | -- | |
Other Inc / (Exp) | -- | -- | -- | -- | -- | |
Operating Expenses | $137.4M | $120.1M | $157.9M | $185.7M | $183.1M | |
Operating Income | $107.2M | $126.8M | $119.2M | $189M | $203.1M | |
Net Interest Expenses | $59M | $43.8M | $49.4M | $41.3M | $36.8M | |
EBT. Incl. Unusual Items | $34.9M | $104.4M | $55.8M | $134.7M | $162M | |
Earnings of Discontinued Ops. | -- | -- | -- | $397.5M | $295.7M | |
Income Tax Expense | $37.4M | $21.3M | $12.9M | $33.7M | $41M | |
Net Income to Company | -- | -- | -- | -- | -- | |
Minority Interest in Earnings | -- | -- | -$4.3M | -$13M | -$20M | |
Net Income to Common Excl Extra Items | -$2.4M | $83M | $38.7M | $485.5M | $396.7M | |
Basic EPS (Cont. Ops) | -$0.00 | $0.07 | $0.03 | $0.42 | $0.34 | |
Diluted EPS (Cont. Ops) | -$0.00 | $0.07 | $0.03 | $0.42 | $0.34 | |
Weighted Average Basic Share | $1.2B | $1.2B | $1.2B | $1.2B | $1.2B | |
Weighted Average Diluted Share | $1.2B | $1.2B | $1.2B | $1.2B | $1.2B | |
EBITDA | $210.9M | $277.2M | $241.7M | $334.5M | $342M | |
EBIT | $75.9M | $136.9M | $88.1M | $153.2M | $175.7M | |
Revenue (Reported) | $3.4B | $3.4B | $3.3B | $4B | $4.4B | |
Operating Income (Reported) | $107.2M | $126.8M | $119.2M | $189M | $203.1M | |
Operating Income (Adjusted) | $75.9M | $136.9M | $88.1M | $153.2M | $175.7M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | $15.9B | $16.7B | $15.3B | $17.3B | $19.6B | |
Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
Cost of Revenues | $14.2B | $15.1B | $13.7B | $15.5B | $17.4B | |
Gross Profit | $1.7B | $1.6B | $1.6B | $1.8B | $2.1B | |
Gross Profit Margin | -- | -- | -- | -- | -- | |
R&D Expenses | -- | -- | -- | -- | -- | |
Selling, General & Admin | -- | -- | -- | -- | -- | |
Other Inc / (Exp) | -- | -- | -- | -- | -- | |
Operating Expenses | $704.1M | $580.3M | $689.6M | $688.1M | $768.8M | |
Operating Income | $948.9M | $975.4M | $952.7M | $1.1B | $1.4B | |
Net Interest Expenses | $267.1M | $188.8M | $95.4K | $274.1M | -- | |
EBT. Incl. Unusual Items | $382.5M | $948.4M | $973.2M | $982.2M | $2B | |
Earnings of Discontinued Ops. | $1.2M | -- | -$4.2M | $385.7M | -$486.4M | |
Income Tax Expense | $39.7M | $178.9M | $46.5M | $160.5M | $317.5M | |
Net Income to Company | -- | -- | -- | -- | -- | |
Minority Interest in Earnings | -$2.3M | -$1.2M | -$10.5M | -$36.8M | -$74.5M | |
Net Income to Common Excl Extra Items | $342.8M | $768.3M | $912.1M | $1.2B | $1.1B | |
Basic EPS (Cont. Ops) | $0.30 | $0.67 | $0.79 | $1.02 | $0.95 | |
Diluted EPS (Cont. Ops) | $0.30 | $0.67 | $0.79 | $1.02 | $0.95 | |
Weighted Average Basic Share | ||||||
Weighted Average Diluted Share | ||||||
EBITDA | $1.2B | $1.8B | $1.7B | $1.8B | $2.8B | |
EBIT | $652.9M | $1.2B | $1.1B | $1.2B | $2.1B | |
Revenue (Reported) | $15.9B | $16.7B | $15.3B | $17.3B | $19.6B | |
Operating Income (Reported) | $948.9M | $975.4M | $952.7M | $1.1B | $1.4B | |
Operating Income (Adjusted) | $652.9M | $1.2B | $1.1B | $1.2B | $2.1B |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | $3.4B | $3.4B | $3.3B | $4B | $4.4B | |
Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
Cost of Revenues | $3.1B | $3.1B | $3B | $3.6B | $4B | |
Gross Profit | $244.6M | $246.9M | $277.1M | $374.7M | $386.2M | |
Gross Profit Margin | -- | -- | -- | -- | -- | |
R&D Expenses | -- | -- | -- | -- | -- | |
Selling, General & Admin | -- | -- | -- | -- | -- | |
Other Inc / (Exp) | -- | -- | -- | -- | -- | |
Operating Expenses | $137.4M | $120.1M | $157.9M | $185.7M | $183.1M | |
Operating Income | $107.2M | $126.8M | $119.2M | $189M | $203.1M | |
Net Interest Expenses | $59M | $43.8M | $49.4M | $41.3M | $36.8M | |
EBT. Incl. Unusual Items | $34.9M | $104.4M | $55.8M | $134.7M | $162M | |
Earnings of Discontinued Ops. | -- | -- | -- | $397.5M | $295.7M | |
Income Tax Expense | $37.4M | $21.3M | $12.9M | $33.7M | $41M | |
Net Income to Company | -- | -- | -- | -- | -- | |
Minority Interest in Earnings | -- | -- | -$4.3M | -$13M | -$20M | |
Net Income to Common Excl Extra Items | -$2.4M | $83M | $38.7M | $485.5M | $396.7M | |
Basic EPS (Cont. Ops) | -$0.00 | $0.07 | $0.03 | $0.42 | $0.34 | |
Diluted EPS (Cont. Ops) | -$0.00 | $0.07 | $0.03 | $0.42 | $0.34 | |
Weighted Average Basic Share | $1.2B | $1.2B | $1.2B | $1.2B | $1.2B | |
Weighted Average Diluted Share | $1.2B | $1.2B | $1.2B | $1.2B | $1.2B | |
EBITDA | $210.9M | $277.2M | $241.7M | $334.5M | $342M | |
EBIT | $75.9M | $136.9M | $88.1M | $153.2M | $175.7M | |
Revenue (Reported) | $3.4B | $3.4B | $3.3B | $4B | $4.4B | |
Operating Income (Reported) | $107.2M | $126.8M | $119.2M | $189M | $203.1M | |
Operating Income (Adjusted) | $75.9M | $136.9M | $88.1M | $153.2M | $175.7M |
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Cash and Equivalents | $2.7B | $2.8B | $1.6B | $2.7B | $2.7B | |
Short Term Investments | -- | -- | -- | -- | -- | |
Accounts Receivable, Net | $3.7B | $3.6B | $3.6B | $4.1B | $4B | |
Inventory | $5.2B | $4.5B | $4.6B | $5.2B | $5.9B | |
Prepaid Expenses | $2.1B | $1.8B | $1.3B | $1.3B | $1.1B | |
Other Current Assets | $141.4M | $137M | $108.3M | $152.5M | $190.4M | |
Total Current Assets | $18.7B | $17.6B | $15.7B | $18.1B | $18.9B | |
Property Plant And Equipment | $3.1B | $3B | $3.1B | $3.4B | $3.6B | |
Long-Term Investments | -- | -- | -- | -- | -- | |
Goodwill | $4.5B | $4.3B | $4.2B | $4.3B | $4.7B | |
Other Intangibles | $3.7B | $3.7B | $3.7B | $4.1B | $4.4B | |
Other Long-Term Assets | $18.4M | $17M | $31.1M | $32.1M | $27.1M | |
Total Assets | $33.3B | $32.1B | $30.7B | $33.9B | $35B | |
Accounts Payable | $4.5B | $3.8B | $3.3B | $3.6B | $3.9B | |
Accrued Expenses | -- | -- | -- | -- | -- | |
Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
Current Portion Of Capital Lease Obligations | $92.2M | $92.8M | $83.6M | $87.3M | $88.4M | |
Other Current Liabilities | $687.5M | $996.4M | $442.9M | $459.8M | $532.8M | |
Total Current Liabilities | $19.6B | $17.7B | $16.3B | $18.8B | $19.6B | |
Long-Term Debt | $4B | $3.9B | $3.3B | $2.6B | $1.9B | |
Capital Leases | -- | -- | -- | -- | -- | |
Total Liabilities | $26.8B | $24.8B | $22.4B | $24.5B | $24.4B | |
Common Stock | $3.1B | $2.9B | $2.7B | $2.8B | $2.6B | |
Other Common Equity Adj | -- | -- | -- | -- | -- | |
Common Equity | $6.5B | $7.3B | $7.7B | $8.6B | $9.4B | |
Total Preferred Equity | -- | -- | -- | -- | -- | |
Minority Interest, Total | $13.5M | $30.6M | $553.4M | $841.2M | $1.3B | |
Total Equity | $6.5B | $7.3B | $8.3B | $9.5B | $10.6B | |
Total Liabilities and Equity | $33.3B | $32.1B | $30.7B | $33.9B | $35B | |
Cash and Short Terms | $2.7B | $2.8B | $1.6B | $2.7B | $2.7B | |
Total Debt | $5.1B | $4.7B | $4.3B | $4.8B | $4.2B |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Cash and Equivalents | $478.3M | -- | -- | -- | $2B | |
Short Term Investments | -- | -- | -- | -- | -- | |
Accounts Receivable, Net | $3.4B | $3.8B | $3.7B | $4.1B | $4B | |
Inventory | $2.6B | $1.7B | $1.2B | $1.1B | $1.7B | |
Prepaid Expenses | -- | -- | -- | -- | -- | |
Other Current Assets | -- | -- | -- | -- | -- | |
Total Current Assets | $6.5B | $5.5B | $4.9B | $5.2B | $7.7B | |
Property Plant And Equipment | -- | -- | -- | -- | -- | |
Long-Term Investments | -- | -- | -- | -- | -- | |
Goodwill | -- | -- | -- | -- | -- | |
Other Intangibles | -- | -- | -- | -- | -- | |
Other Long-Term Assets | -- | -- | -- | -- | -- | |
Total Assets | -- | -- | -- | -- | -- | |
Accounts Payable | $3.7B | $3.2B | $2.8B | $3.4B | $4.1B | |
Accrued Expenses | -- | -- | -- | -- | -- | |
Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
Current Portion Of Capital Lease Obligations | $76.2M | -- | -- | -- | $97.4M | |
Other Current Liabilities | -- | -- | -- | -- | -- | |
Total Current Liabilities | $3.8B | $3.2B | $4B | $4.6B | $4.2B | |
Long-Term Debt | -- | -- | -- | -- | -- | |
Capital Leases | -- | -- | -- | -- | -- | |
Total Liabilities | -- | -- | -- | -- | -- | |
Common Stock | -- | -- | -- | -- | -- | |
Other Common Equity Adj | -- | -- | -- | -- | -- | |
Common Equity | -- | -- | -- | -- | -- | |
Total Preferred Equity | -- | -- | -- | -- | -- | |
Minority Interest, Total | $12.9M | $30.1M | $558.3M | $1.2B | $1.3B | |
Total Equity | -- | -- | -- | -- | -- | |
Total Liabilities and Equity | -- | -- | -- | -- | -- | |
Cash and Short Terms | $478.3M | -- | -- | -- | $2B | |
Total Debt | -- | -- | -- | -- | -- |
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | $277.5M | $694.5M | $982.9M | $752.4M | $1.3B | |
Depreciation & Amoritzation | $907.9M | $573.8M | $581.1M | $616M | $717.6M | |
Stock-Based Compensation | -- | -- | -- | -- | -- | |
Change in Accounts Receivable | -- | -- | -- | -- | -- | |
Change in Inventories | -$190.7M | $577.4M | $218.3M | -$419M | -$938.4M | |
Cash From Operations | $314.1M | $877.9M | $1.2B | $1.3B | $1.7B | |
Capital Expenditures | $355.2M | $727.7M | $803.6M | $846.6M | $968.7M | |
Cash Acquisitions | -- | -- | -- | -- | -- | |
Cash From Investing | -$500.2M | -$640.1M | -$834.2M | -$283.6M | -$815M | |
Dividends Paid (Ex Special Dividend) | -$92.5M | -- | -$84.4M | -$89.9M | -$191.6M | |
Special Dividend Paid | ||||||
Long-Term Debt Issued | $676.1M | $946.5M | -- | -- | -- | |
Long-Term Debt Repaid | -$58.2M | -$874.4M | -$1.5B | -$20.6M | -$690.5M | |
Repurchase of Common Stock | -- | -- | -- | -- | -- | |
Other Financing Activities | -- | -$36.7M | $69.6M | $97.4M | $148.3M | |
Cash From Financing | $525.3M | $35.5M | -$1.5B | -$13M | -$733.8M | |
Beginning Cash (CF) | $2.2B | $2.6B | $2.6B | $1.6B | $2.6B | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | $339.2M | $273.3M | -$1.1B | $987.3M | $119.1M | |
Ending Cash (CF) | $2.5B | $2.9B | $1.6B | $2.6B | $2.8B | |
Levered Free Cash Flow | -$41.1M | $150.3M | $411.3M | $437.4M | $699.2M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | -- | -- | -- | -- | -- | |
Depreciation & Amoritzation | -- | -- | -- | -- | -- | |
Stock-Based Compensation | -- | -- | -- | -- | -- | |
Change in Accounts Receivable | -- | -- | -- | -- | -- | |
Change in Inventories | -- | -- | -- | -- | -- | |
Cash From Operations | -$1.6B | -$1.1B | -$667M | -$674.5M | -$610.3M | |
Capital Expenditures | -- | -- | -- | -- | -- | |
Cash Acquisitions | -- | -- | -- | -- | -- | |
Cash From Investing | -$132.6M | -$115.6M | -$12.9M | -$13M | $303M | |
Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -$6.3M | |
Special Dividend Paid | -- | -- | -- | -- | -- | |
Long-Term Debt Issued | -- | -- | -- | -- | -- | |
Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
Repurchase of Common Stock | -- | -- | -- | -- | -- | |
Other Financing Activities | -- | -- | -- | -- | -- | |
Cash From Financing | -- | -- | $9.7M | $9.8M | -$392.5M | |
Beginning Cash (CF) | $2.7B | $2.8B | $2.6B | $2.6B | $2.7B | |
Foreign Exchange Rate Adjustment | $20.5M | $10.1M | $37.6M | $38M | -$14.7M | |
Additions / Reductions | -$1.7B | -$1.2B | -$670.2M | -$677.8M | -$699.7M | |
Ending Cash (CF) | $491.6M | $429.8M | $2B | $2B | $2B | |
Levered Free Cash Flow | -$1.6B | -$1.1B | -$667M | -$674.5M | -$610.3M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | -- | -- | -- | -- | -- | |
Depreciation & Amoritzation | -- | -- | -- | -- | -- | |
Stock-Based Compensation | -- | -- | -- | -- | -- | |
Change in Accounts Receivable | -- | -- | -- | -- | -- | |
Change in Inventories | -- | -- | -- | -- | -- | |
Cash From Operations | $377.4M | $1.4B | $1.6B | $1.3B | $1.7B | |
Capital Expenditures | $355.2M | $727.7M | $803.6M | $846.6M | $968.7M | |
Cash Acquisitions | -- | -- | -- | -- | -- | |
Cash From Investing | -$519.1M | -$623.1M | -$731.5M | -$283.8M | -$498.9M | |
Dividends Paid (Ex Special Dividend) | -$92.5M | -- | -$84.4M | -$89.9M | -$197.9M | |
Special Dividend Paid | ||||||
Long-Term Debt Issued | -- | -- | -- | -- | -- | |
Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
Repurchase of Common Stock | -- | -- | -- | -- | -- | |
Other Financing Activities | -- | -- | -- | -- | -- | |
Cash From Financing | -- | -- | -$1.5B | -$12.9M | -$1.1B | |
Beginning Cash (CF) | -- | -- | -- | -- | -- | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | $9.5M | $773.8M | -$555M | $979.8M | $97.1M | |
Ending Cash (CF) | -- | -- | -- | -- | -- | |
Levered Free Cash Flow | $22.2M | $633.8M | $841.7M | $429.8M | $1.7B |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | -- | -- | -- | -- | -- | |
Depreciation & Amoritzation | -- | -- | -- | -- | -- | |
Stock-Based Compensation | -- | -- | -- | -- | -- | |
Change in Accounts Receivable | -- | -- | -- | -- | -- | |
Change in Inventories | -- | -- | -- | -- | -- | |
Cash From Operations | -$1.6B | -$1.1B | -$667M | -$674.5M | -$610.3M | |
Capital Expenditures | -- | -- | -- | -- | -- | |
Cash Acquisitions | -- | -- | -- | -- | -- | |
Cash From Investing | -$132.6M | -$115.6M | -$12.9M | -$13M | $303M | |
Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -$6.3M | |
Special Dividend Paid | -- | -- | -- | -- | -- | |
Long-Term Debt Issued | -- | -- | -- | -- | -- | |
Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
Repurchase of Common Stock | -- | -- | -- | -- | -- | |
Other Financing Activities | -- | -- | -- | -- | -- | |
Cash From Financing | -- | -- | $9.7M | $9.8M | -$392.5M | |
Beginning Cash (CF) | $2.7B | $2.8B | $2.6B | $2.6B | $2.7B | |
Foreign Exchange Rate Adjustment | $20.5M | $10.1M | $37.6M | $38M | -$14.7M | |
Additions / Reductions | -$1.7B | -$1.2B | -$670.2M | -$677.8M | -$699.7M | |
Ending Cash (CF) | $491.6M | $429.8M | $2B | $2B | $2B | |
Levered Free Cash Flow | -$1.6B | -$1.1B | -$667M | -$674.5M | -$610.3M |
Signup to receive the latest stock alerts
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Market Cap: $4.2T
P/E Ratio: 58x
Market Cap: $3.8T
P/E Ratio: 43x
Market Cap: $3.1T
P/E Ratio: 35x
SharpLink Gaming [SBET] is down 2.6% over the past day.
Exodus Movement [EXOD] is down 4.14% over the past day.
Unity Software [U] is up 7.51% over the past day.